Bank Of New York Mellon Corp Finch Therapeutics Group, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.91 - $5.11 $47,820 - $127,939	-25,037 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$5.02 - $10.47 $2,836 - $5,915	-565 Reduced 2.21%	25,037 $126,000
Q4 2021 Feb 11, 2022	BUY	$8.95 - $16.88 $3,544 - $6,684	396 Added 1.57%	25,602 $255,000
Q3 2021 Nov 12, 2021	BUY	$12.2 - $16.75 $120,548 - $165,506	9,881 Added 64.48%	25,206 $328,000
Q2 2021 Aug 11, 2021	BUY	$12.03 - $17.51 $184,359 - $268,340	15,325 New	15,325 $215,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $575M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.